2) was 2.4 (95% CI: 1.3-4.4) times as high as in the ever-smoking Swiss population in the same age group. Smoking tobacco (92.0%) and substance inhalation (cannabis: 97.6%, cocaine: 69.6%, heroin: 68.0%) were highly prevalent among all participants. The participants expressed considerable interest in lifestyle changes and use of therapeutic offers for COPD management, with smoking cessation being least (20.2% of tobacco smokers interested), and pharmacological treatment to alleviate COPD symptoms most popular.

CONCLUSIONS:

In Switzerland, chronic obstructive pulmonary disease (COPD) and multiple risk factors for COPD appear to be high among people in opioid agonist treatment (OAT) compared with the general population. OAT patients appear to develop COPD at a younger average age compared with the general population and are open to lifestyle changes and other COPD management approaches.

This article is protected by copyright. All rights reserved.

KEYWORDS:

Chronic obstructive pulmonary disease; case finding; opioid agonist treatment; opioid dependence; opioid substitution treatment; people with opioid use disorder; screening; spirometry

PMID: 30675957 DOI: 10.1111/add.14559 Share Supplemental Content —

View the Original article

Partage le savoir
error: Content is protected !!